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Articular cartilage was thought to be one of the first tissues to be successfully engineered. Despite the avascular
and non-innervated nature of the tissue, the cells within articular cartilage – chondrocytes – account for a complex
phenotype that is difficult to be maintained in vitro. The use of bone marrow–derived stromal cells (BMSCs) has
emerged as a potential solution to this issue. Differentiation of BMSCs toward stable and non-hypertrophic
chondrogenic phenotypes has also proved to be challenging. Moreover, hyaline cartilage presents a set of
mechanical properties – relatively high Young's modulus, elasticity, and resilience – that are difficult to reproduce.
Here, we report on the use of additive manufactured biodegradable poly(ester)urethane (PEU) scaffolds of two
different structures (500 μm pore size and 90 or 60 deposition angle) that can support the loads applied onto the
knee while being highly resilient, with a permanent deformation lower than 1% after 10 compression-relaxation
cycles. Moreover, these scaffolds appear to promote BMSC differentiation, as shown by the deposition of gly-
cosaminoglycans and collagens (in particular collagen II). At gene level, BMSCs showed an upregulation of
chondrogenic markers, such as collagen II and the Sox trio, to higher or similar levels than that of traditional
pellet cultures, with a collagen II/collagen I relative expression of 2–3, depending on the structure of the scaffold.
Moreover, scaffolds with different pore architectures influenced the differentiation process and the final BMSC
phenotype. These data suggest that additive manufactured PEU scaffolds could be good candidates for cartilage
tissue regeneration in combination with microfracture interventions.1. Introduction
Hyaline cartilage is the connective tissue present at the end of long
bones, serving as a cushion and allowing for frictionless movement upon
articulation [1,2]. The cartilage has poor self-healing properties. Damage
to the tissue, by trauma or as a consequence of degenerative diseases,
results in the evolution of the formed defect until the subchondral bone is
reached, leading in many cases to disability of the patient. Clinical
treatments to regenerate cartilage are based on the expansion of autol-
ogous chondrocytes and later implantation on the defect area, with or
without the aid of a matrix support (autologous chondrocyte implanta-
tion [ACI] or matrix-assisted ACI [MACI]), or the recruitment of bone
marrow–derived stem cells (BMSCs) from the subchondral bone [3]. Inuniversity.nl (S. Camarero-Espino
rm 1 April 2020; Accepted 5 Apr
vier Ltd. This is an open access aboth cases, cells invading the defect form a de-novo tissue that differs
from the native one morphologically, histochemically, and, most
importantly, biomechanically. While these methods result in an initial
pain relief for the patient, at long term these fail to regenerate a func-
tional tissue [3,4].
Avascular and non-innervated in nature, articular cartilage was
expected to be one of the first tissues to be successfully engineered in
vitro [5,6]. However, autologous chondrocytes have low availability
(1–5% of total tissue volume) and low proliferative character, and in
vitro expansion leads to the dedifferentiation of the cells [7]. Thus, the
use of BMSCs has emerged as an optimal solution to these limitations.
Differentiation of BMSCs toward chondrogenic phenotypes in hydrogels
and pellet cultures has been largely studied [8–10]. However, while thesesa).
il 2020
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S. Camarero-Espinosa et al. Materials Today Bio 6 (2020) 100051systems recapitulate the events observed during in vivo endochondral
bone formation, they lack sufficient support to withstand the high and
repetitive loads applied onto the knee. Thus, research has been focused
on developing chondroinductive materials and biofabrication processes
that allow generation of scaffolds which are able to promote chondro-
genic differentiation of BMSCs and withstand the cyclic loads applied on
the tissue [11].
Hydrogel systems have been extensively studied because of their
intrinsic capability to maintain a rounded cellular structure that favors
chondrogenic phenotypes and their highly hydrated state similar to that
of the cartilage (80 wt% water) [8]. These have been fabricated out of
naturally derived materials such as alginate, silk, and collagen, as well as
synthetic polymers such as poly(ethylene glycol) [12]. Hydrogels usually
present a high resilience, similarly to the native tissue, but account for a
reduced Young's modulus. Therefore, many efforts have been focused on
the reinforcement of such materials with fillers or fibrous structures
[13–18]. Others have explored various scaffold fabrication techniques
such as salt leaching, gas foaming, or thermally induced phase separa-
tions to create porous scaffolds that can host the cells while providing a
higher mechanical integrity [19–21]. The use of fibrous scaffolds fabri-
cated via spinning has also been investigated with relative success due to
the difficulty to generate 3D scaffolds and the low-porosity nature that
hinders cell infiltration [22,23].
Fused deposition modeling (FDM) has emerged on the last decades as
a rapid and patient-centered biofabrication technique that allows for the
layer-by-layer deposition of a great variety of materials. The use of this
additive manufactured scaffold for cartilage tissue engineering or
regeneration has shown great promise because of the flexibility of the
technique on materials, structures, and mechanical properties of the
generated scaffolds [24]. Traditional polyesters used in FDM such as
polycaprolactone and poly(lactic acid) or polyether-based elastomers,
such as poly(ethylene oxide) terephthalate/poly(butylene) tere-
phthalate, have shown success on in vitro engineering of the articular
cartilage [25–28]. However, these materials generally present a high
Young's modulus but a rather low elasticity, yield strain and resilience
[29,30]. To tackle this problem, researchers have combined hydrogels
with polyester-based FDM scaffolds. These composite scaffolds present
the capability of supporting cell chondrogenesis, while supporting the
loads applied onto the knee [16,31]. The use of materials that offer high
compressive strength while being highly resilient, such as poly(ester)
urethanes , has so far been limited to solvent-based biofabrication tech-
niques [32–37]. Zuidema et al. [38] reported on the in vitro biodegra-
dation of solvent-based fabricated PEU foams based on a prepolymer of
50 mol% DL-lactide (50/50 D/L ratio) and 50 mol% ε-caprolactone
mixture that was later chain extended with a urethane hard segment
(BDI-BDO-BDI-BDO-BDI). The degradation products of this PEU have
proven biocompatible in vitro, and a PEU based on the same building
blocks of hard segment but with a shorter length (BDO-BDI-BDO), has
proven bioresorbable in a 3-year subcutaneous implantation study in rats
and rabbits [39,40]. We have recently reported the use of FDM of
biodegradable PEUs of the same composition as from the study by Zui-
dema et al. [38] for cartilage tissue engineering [41]. Additive
manufacturing offers the possibility of creating scaffolds with different
internal structure or mesh. Variations on the pore size and shape of the
mesh have shown to exert an effect on the mechanical properties of the
final object and on the differentiation potential of the cells cultured
within these [26,41–43]. The fabricated PEU scaffolds showed an
extended elastic region with yield strains of up to 50% and a Young's
modulus that can be tuned with the scaffold architecture. These materials
supported the redifferentiation of dedifferentiated chondrocytes even in
basal conditions (no growth factors or chondroinductive molecules
added to themedia) and performed better than traditional pellet cultures.
Here, we report on the additive manufacturing of highly resilient PEU
scaffolds with printing patterns of 90 and 60, of the same chemical
characteristics, that support the differentiation of BMSCs toward a
chondrogenic phenotype.2
2. Materials and methods
2.1. Materials
The biodegradable PEU used for this study was synthesized and
kindly provided by Polyganics B.V. in the form of pellets and was used as
received. The PEU was synthesized from a random, polyester prepolymer
soft segment that was chain extendedwith a hard urethane segment [44].
In brief, the soft segment prepolymer was prepared by ring opening
polymerization of a 50 mol% DL-lactide (50/50 D/L ratio) and 50 mol%
ε-caprolactone mixture with butanediol as the initiator. The prepolymer
(Mn ¼ 2000 g/mol) was then chain extended with a uniform 5-block
urethane hard segment (BDI-BDO-BDI-BDO-BDI), where BDI and BDO
stand for 1,4- butanediisocyanate and 1,4-butanediol, respectively.
2.2. Fused deposition modeling
The scaffolds produced and tested in this study were fabricated with a
BioScaffolder system (SysEng) equipped with a temperature controller
and a G22 needle (400 μm internal diameter). PEU was deposited with a
pore size and shape (angle of deposition) of 500 μm and 90 and 500 μm
and 60 (Fig. 1). The polymer deposition was driven at a feed (travel) rate
of 350 mm/R, a dispensing speed of 30 RPM, dispensing pressure of
0.8 MPa, and with a layer thickness of 0.3 mm. The optimal printing
temperature to avoid degradation of the polymer was found to be
175 C [41].
2.3. Spin coating of 2D PEU films
Glass coverslips of 12 mm diameter (Fisher Scientific) were cleaned
by placing them in 50 mL centrifugation tubes and consequently
submerging the slides in isopropanol. The centrifugation tubes were
then placed on a Branson 2510 ultrasonic cleaner and sonicated for 15
min. The isopropanol was then removed, and the coverslips were
rinsed two times more in clean isopropanol. PEU was dissolved at a
concentration of 20 mg/mL in CHCl3 (Sigma-Aldrich) and spin coated
on top of precleaned glass coverslips. Spin coating was performed
using a homemade instrument in 2 steps. In the first step, the PEU
solution was added dropwise over a time of 30 s with a slide rotation
speed of 1500 rpm. After addition of the polymer, the rotation speed
was increased to 3000 rpm which allowed for film formation and
CHCl3 evaporation.
2.4. Cell culture
Human BMSCs were isolated from a 22-year-old male donor by
aspiration by Texas A&M Health Science Center after ethical approval
from the local and national authorities and written consent from the
donor [45]. Mononuclear cells were isolated by centrifugation, and iso-
lated BMSCs were verified for differentiation capacity. Cryopreserved
vials at passage 2 were plated at a density of 1000 cells/cm2 and cultured
in alpha MEM (minimum essential media) supplemented with GlutaMax
(Gibco, Massachusetts, USA) and 10% fetal bovine serum (FBS) (Sig-
ma-Aldrich, Missouri, USA) (basal or maintenance media). Cells were
subcultured at 80% confluence.
2.5. Cell culture on 2D substrates
PEU spin-coated glass coverslips were placed on a 24-well plate and
sterilized by submerging them in 70% ethanol for 15 min. Afterward,
samples were washed three times with Dubelcco's phosphate buffered
saline (PBS, Gibco). After the last wash, BMSCs were seeded at a density
of 5000 cell/cm2 on a volume of approximately 25 μL of α-MEM sup-
plemented with GlutaMax (no FBS was used). After 24 h, samples were
placed in new 24-well plates. For cell attachment experiments, samples
were rinsed with PBS and fixed with 4% paraformaldehyde for 15 min,
Fig. 1. Structural, mechanical, and biocompatibility characterization. Scanning electron microscopy images of (a and b) scaffolds with 500 μm and 90 and (c and d)
500 μm and 60 deposition pattern under top (a and c) and side (b and d) views. Scale bars are 500 μm. Cyclic compression of scaffolds fabricated with 60 (e) and 90
(f) pore angles. Insets show zoom-in of the 0–1% strain range. (g) Young's modulus of the scaffolds at first (C1), fifth (C5), and tenth (C10) cycle of compression
showing no statistically differences between cycles. (h) Representative strain-stress curves of compression experiments. BMSC viability after 72 h of culture on PEU 2D
films (i) and cell surface density after 24 h (j). Fluorescence microscopy images of BMSCs after culture on PEU and TCP (tissue culture plate, polystyrene) (k).
Attachment shows cells adhered to the different material substrates and stained for F-actin (Phalloidin, green) and DNA (Hoechst, blue). Alive and dead panels show
cells simultaneously stained with calcein (green, alive) and ethidium bromide homodimer (red, dead). Scale bar is 200 μm. (For interpretation of the references to
colour in this figure legend, the reader is referred to the Web version of this article.) BMSC, bone marrow–derived stem cell, PEU, poly(ester)urethane.
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meabilized for 10 min in a 0.1% Triton X 100 solution in PBS. Samples
were stained for F-actin and DNA with Phalloidin Alexa Fluor-488
(1:100, 1 h) and Hoechst (1:2000, 10 min), respectively. For cell
viability studies, medium was replaced after 24 h with fresh α-MEM
supplemented with GlutaMax and 10% FBS. After 72 h of culture, cells
were rinsed with PBS and a live/dead viability kit consisting of ethidium
homodimer and calcein (Thermo Fisher) was used to stain cells following
the manufacturer's indications. After 30 min of incubation, cells were
imaged using a Nikon TI-E epifluorescent microscope and analyzed using
FiJi and CellProfiler free software.
2.6. Cell culture in FDM scaffolds
2.6.1. Cell seeding
Scaffolds of PEU with a 500 μm pore size and a pore angle of 90 and
60 were cut using a biopsy puncher to obtain cylindrical samples of 4 mm
diameter and 4 mm height. Samples were distributed on 50 mL centrifu-
gation tubes and sterilized by immersing them in a 70% ethanol solution3
for 15 min, after which samples were washed thoroughly with PBS three
times. To promote initial cell attachment, samples were coated with
truncated recombinant human vitronectin (Thermo Fisher), a protein
commonly used for the culture of pluripotent stem cells. Vitronectin coats
the scaffolds in a non-specific manner and is washed away after media
changes. Vitronectin coating was performed at a concentration of 1 μg/
cm2, assuming a surface area per scaffold of 16 mm2. In brief, vitronectin
stock solution was diluted in PBS to reach a concentration of 1 μg/mL1.
The scaffolds were distributed in 15 mL falcon tubes and covered with the
vitronectin solution at a ratio of 6 scaffolds per each 1 mL of solution. The
coating was left to proceed at room temperature (RT) for 1 h in an orbital
shaker. Afterward, samples were placed on 24-well plates, and
1.8⋅105 cells per scaffolds (3.6⋅106 cell/cm3) were seeded at a concen-
tration of 3.6⋅106 cell/mL (that is 50 μL of cell dispersion per scaffold)
without previous scaffold rinsing. Cells were left to attach to the scaffolds
for 2 h in the incubator (37 C, 5% CO2). Thereafter, the scaffolds were
flipped and left to incubate for another 2 h. After 4 h of initial cell seeding,
1.5 mL of basic medium supplemented with penicillin (100 units/mL) and
streptomycin (100 μg/mL) was added to each well (1 scaffold per well).
Fig. 2. Glycosaminoglycan (GAG) deposition and cell proliferation. (a) Optical microscopy images of the cross-section and top views of scaffolds cultured for 14 and
28 days in basal (control) or differentiation media (differentiation) and stained with Safranin-O (GAGs, dark pink) and counter stained with Weigert's iron hematoxylin
(black, cell nuclei). Scale bar is 1 mm. (b) Cell number populating the scaffolds after 24 h of seeding and 14 and 28 days of culture in either basal (maintenance) or
differentiation medium. (c) Total GAG content and (d) DNA normalized GAG deposition on scaffolds cultured for 14 and 28 days in the maintenance or differentiation
medium. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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The samples were cultured for 7 days in basal media. After this
period, the differentiation process was started, when relevant. Samples
for differentiation studies were cultured in chondrogenic media con-
sisting of high glucose (4.5 mg/mL) DMEM (Dubelcco`s Modified Eagle
Medium) with 100 μg/mL of sodium pyruvate (Gibco), 0.2 mM L-ascorbic
acid-2-phosphate (Sigma-Aldrich), 1% 100x ITS (insulin-transferrin-se-
lenium) liquid media supplement (Thermo Fisher Scientific), 40 μg/mL
proline (Sigma-Aldrich), 100 U/mL penicillin/streptomycin, and 100 nM
dexamethasone (Sigma-Aldrich). To the complete media and right before
addition to the cultures, 0.01ug/mL of transforming growth factor-
β3 was supplemented (Peprotech). Media for both maintenance and
differentiation conditions were changed every second day.
2.7. Cell pellet culture
BMSCs were cultured on pellets as a positive control of the experi-
ment because this method is a ‘gold standard’ for in vitro chondrogenesis
of stem cells. To form pellets, 0.25⋅106 cells were placed in a 15 mL
polypropylene tube with 500 μL maintenance media and centrifuged at
500 rcf for 5 min to form a flat pellet at the bottom of the tube. The tubes
were left (covered with the cap but allowing gas transfer) in the incubator
for 24 h after which rounded pellets were spontaneously formed. After
24h of seeding, media were replaced for differentiation or maintained in
basic media conditions (control of the control pellets). Media change was
performed every second day, as for the scaffolds.4
2.8. DNA assay
For DNA assays, samples were harvested and placed in Eppendorf
tubes. Samples were first frozen at 80 C and then thawed at room
temperature (RT), this process was repeated 3 times. The extracellular
matrix was digested by a proteinase K treatment. In brief, samples were
placed in 1.5 mL Eppendorf tubes and incubated overnight at 56 C with
250 μL of 50 mM Tris/1 mM ethylenediaminetetraacetic acid/1 mM
iodoacetamide solution containing 1 mg/mL1 proteinase K and 10 μg/mL
pepstatin A. After sample digestion, the samples were freeze-thawed 3
times in liquid N2 to facilitate the DNA extraction. DNA was measured
with a CyQuant cell proliferation assay kit (Thermo Fisher). In brief,
cellular RNA was degraded by incubating the samples for 1 h at RT with
lysis buffer containing RNase A. 100 μL of each sample (triplicates) were
placed in a 96 well plate, and 100 μL of 2x GR-dye solution were added
and left to incubate for 15 min at RT. A standard curve was prepared with
a DNA standard solution, and fluorescence intensity was measured at
520 nm.
2.9. Glycosaminoglycan assay
Samples from proteinase K digestion step (DNA assay) were used to
measure glycosaminoglycan (GAG) content using a 1,9-dimethyl-meth-
ylene blue zinc chloride double salt ([DMMB], Sigma-Aldrich) solution
(16 mg DMMB in 5 mL ethanol). In brief, 150 μL of DMMB solution was
mixed with 25 μL of the sample and 5 μL of 2.3 M NaCl on a black well
S. Camarero-Espinosa et al. Materials Today Bio 6 (2020) 100051plate; the absorbance difference at 525 and 595 nm was measured. Data
were compared with a standard curve prepared with chondroitin sulfate
from shark cartilage (Sigma-Aldrich).
2.10. Histology
Scaffold-tissue constructs for histological analysis were cut opened
along the height axis. Samples stained for GAGs were first stained for
10 min in Weigert's iron hematoxylin solution (Sigma-Aldrich) to coun-
terstain the cell nucleus black, washed thoroughly in running tap water
and stained for 3 min with Fast green solution (Sigma-Aldrich), and
quickly dipped in 0.5% acetic acid. Finally, samples were stained for
5 min in a 0.1% solution of Safranin-O (Sigma-Aldrich), after which they
were rinsed with PBS until the solution was clear. Picrosirius red
(Abcam) staining was performed following the manufactures’ in-
structions. In brief, samples were incubated for 2 h in Picrosirius red
solution and then rinsed quickly in 0.5% acetic acid solution (both from
Abcam, Cambridge, UK). Afterward, samples were rinsed in PBS 3 times.
2.11. Immunofluorescence
Samples were cut opened by half along the longitudinal axis with a
scalpel and prepared by fixing them in 4% paraformaldehyde for 30 min,
followed by rinsing in PBS and permeabilization for 15 min in a 0.1%
Triton X-100 solution (Millipore Sigma) in PBS. Blocking was performed
for 1 h in a solution of 3% bovine serum albumin (BSA, Sigma-Aldrich)
and 0.01% Triton X-100 in PBS. After rinsing the blocking solution,
samples were incubated for 1 h at RT with mouse anti-collagen I (1:500)
(ab23446, Abcam), rabbit anti-collagen II (1:400) (ab34712, Abcam)
antibodies, and AlexaFluor 564 Phalloidin (1:100) (Thermo Fisher Sci-
entific). After 1 h, incubation was stopped and the solution was rinsed 3
times with 0.3% BSA and 0.01% Triton X-100 in PBS. Secondary anti-
bodies, anti-rabbit AlexaFluor 647, and anti-mouse AlexaFluor-488 (both
from Thermo Fisher Scientific) were incubated in the dark for 30 min at
RT in PBS (1:200), followed by rinsing with PBS and staining with
Hoechst 33342 (1 mg/mL, 1:3000) (Thermo Fisher Scientific) in PBS for
10 min. After final rinsing with PBS, samples were observed under a Leica
TCS SP8 CARS confocal microscope.
2.12. Gene expression
Total RNA was extracted with the RNeasy Minikit with on column
DNase treatment (Qiagen, Hilden, Germany) according to the manufac-
turer's protocol. cDNA was synthesized from 200 ng total RNA, using
iScript cDNA synthesis kit (Bio-Rad, California, USA) on a 20 μL reaction
following manufactures instructions. Real-time polymerasa chain re-
actions (RT-PCRs) were prepared on a total volume of 20 μL with 10 μL iQ
SYBR green Supermix (Bio-Rad), 0.2 μM forward and reverse primers
(Table 1), 3 ng of cDNA and diethylpyrocarbonate (DEPC)-treated water.
For no RT controls, an equivalent volume of DNase- and RNase-free water
was used. A CFX96™ IVD Real-Time PCR system (Bio-Rad) was used with
a thermal cycle of 50 C for 2 min, 95 C for 2 min, and then 95 C for 15 s
and 60 C for 30 s for a total of 40 cycles. Ct values of RT-PCR wereTable 1
List of primers used for RT-PCR experiments.
Gene Forward primer 50 to 30 Reverse primer 50 to 30
GAPDH ATG GGG AAG GTG AAG GTC G TAA AAG CAG CCC TGG TGA CC






Col Xa1 GAC TCC CTC CTC ACT GTC GC AGG GAA GTC TCC CTC ACT TGT
RunX2 AGT GAT TTA GGG CGC ATT CCT GGA GGG CCG TGG GTT CT
5
normalized against the house-keeping gene and analyzed using the ΔΔCt
model [46].
2.13. Mechanical testing
The mechanical properties of the scaffolds were measured before and
after culture. Bare scaffolds were tested in air and cell-scaffold constructs
in PBS. Samples were prepared as cylinders of 4 mm diameter and 4 mm
height. Before the tests, samples were measured with a caliper, and the
dimensions were noted down for data analysis. The compressive me-
chanical properties of the bare scaffolds (dry) with different architectures
and of the scaffold-tissue constructs after different cell culture time (in
PBS) were measured on a TA ElectroForce system (TA Instruments)
equipped with a 450 N load cell under unconfined and non-equilibrium
conditions. The instrument was controlled with Wint7 software. Tests
were conducted at a strain rate of 0.01 mm/s. The experiments were run
until approximately 50% deformation (or until the maximum applicable
load was reached). The Young's modulus was calculated from the slope of
the strain-stress curve between 0.2% and 1.2% engineering strain. The
yield stress and strain were calculated from the stress-strain curves as the
maximum value of the elastic regime before the inflexion point. Cyclic
compression experiments were performed on scaffolds cylinders of 6 mm
diameter and 4 mm height that were also first measured with a caliper.
Tests were conducted up to 10 cycles at a frequency of 0.01 Hz (strain
rate of 0,008 mm/s1) with a 45 N load cell. The experiments were run
until approximately 10–12% deformation (fixed deformation of 0.4 mm).
2.14. Micro computed tomography
Micro computed tomography (μCT) scans were recorded with a
Bruker Skyscan 1272 11Mp scanner with cone beam geometry, equipped
with a 4032  2688 detector. The scanner was air damped to reduced
vibration disturbances. Alignment, thermal drift of the cathode spot,
beam hardening, and ring artefacts were corrected using Bruker's soft-
ware. The isotropic voxel size was 33 μm3. The obtained 3D data sets
were reconstructed using FDK implemented in NRecon 1.7.1.0 (Bruker
microCT) and analyzed with CTAN software (Bruker) [47]. An object
volume (VOI) corresponding to the whole scaffold was selected to bal-
ance potential morphological differences due to printing. The VOI se-
lection was refined to take into account the scaffold morphology
resulting from the deposition pattern used, including an integer amount
of repeating cells. Scaffold parameters such as porosity, Euler number,
volume, and surface area were calculated via the 3D analysis function
available in the software.
2.15. Statistical analysis
Statistical significance was calculated for Young's modulus measure-
ments, DNA assay, GAG assay, and PCR analysis by two-way analysis
of variance (ANOVA) with Tukey's multiple comparison test: (****)
p < 0.0001, (***) p < 0.001, (**) p < 0.01, and (*) p < 0.1.
3. Results
3.1. Fabrication and structural characterization of PEU scaffolds
To assess the functionality of additive manufactured PEUs for the
regeneration of cartilage with BMSCs, scaffolds with pore size and shapes
of 500 μm and 90 or 60 were fabricated. The structure of the FDM
scaffolds was analyzed by scanning electron microscopy (SEM)
(Fig. 1a–d), showing high fidelity with the designed patterns, as previ-
ously reported [41]. Analysis of the scaffolds by μCT revealed porosities of
57 3%and52 3% for the 90 and 60 deposition patterns, respectively
(Table 2 and Fig. 3). A slightly higher closed porosity (a connected
assemblage of space (black) voxels that is fully surrounded on all sides in
3D by solid (white) voxels) was detected for the 60 patterned scaffolds
Table 2
Porosity, closed porosity, total surface area, total available pore volume and connectivity of fabricated scaffolds (assuming a total volume of 50 mm3).
Scaffold pore size and pattern angle Porosity (%) Closed porosity (%) Total surface area (mm2) Total pore volume (mm3) Connectivity (Euler number)
500 μm, 90 57  3 0.19  0.06 549  4 28  1 13834  1777
500 μm, 60 52  3 2.9  0.4 379  20 26  1 6998  2828
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ference between deposition patterns. Consequently, also higher total
surface area and pore volume were measured for scaffolds with 90 pat-
terns. In contrast to these data, and as reported previously, the scaffolds
with a 60 pattern presented a higher connectivity (Euler number, lowest
tortuosity) than that with 90 patterns.3.2. Mechanical properties of additive manufactured scaffolds
The fabricated PEU scaffolds were analyzed by mechanical
compression, and representative stress-strain curves are shown in Fig. 1,
h. The stress-strain traces of the two scaffold architectures present the
typical response of porous materials with an initial elastic regime that is
followed by the collapse of the pores. This usually appears as a plateau in
the curve that in this case is more representative of the 60 patterned
scaffold. On the 90 pattern, however, this area appears as a first
densification regime, probably due to the lower thickness of the pores (2
layers on 90 vs 3 layers on the 60 pattern). After the collapse of the
pores, the structure undergoes the so-called densification step, charac-
terized by an exponential increase of the mechanical properties. TheFig. 3. Extracellular matrix deposition. Laser scanning microscopy (LSM) images (to
tiation medium on scaffolds with 500 μm and 90 or 60 deposition patterns. BMSC
collagen I (green), and collagen II (blue). Scale bar is 100 μm. μCT images (bottom ro
showing ECM deposition. Scale bar is 1 mm and insets are 700  700 μm. (For interp
the Web version of this article.) BMSCs, bone marrow–derived stem cells; μCT, micr
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Young's modulus was calculated from the initial elastic regime of these
curves, resulting on 4.2 0.9 and 3.1 0.8MPa for 90 and 60 patterns,
respectively (Fig. 1g–h). As expected, the deposition pattern influenced
the Young's modulus of the scaffolds. The yield strain (that corresponding
to the yield strength) was of approximately 25% for 90 patterns and 35%
for 60 patterns. While this extended yield strain is common to PEUs, it is
high as compared with traditionally FDM scaffolds of other biopolymers
[29,30]. Cyclic compression experiments with a maximum strain of
10–12% (fixed deformation of 0.4 mm) were performed to test the
resilience of the scaffolds (Fig. 1e–f). The samples showed an outstanding
shape recovery capability with maximum deformations after 10 cycles,
less than 0.5% and 1% for 90 and 60 patterns, respectively (Fig. S1).
The Young's modulus of the scaffolds remained invariable over the
compression cycles (Fig. 1, g).3.3. BMSC viability and attachment on PEU films
Before the investigation of the potential of PEUs as cartilage tissue
engineering scaffolds, the cell viability and capability to adhere to PEU
films was evaluated with BMSCs. Cells attached to PEU films and to thep rows) of BMSCs cultured for 14 and 28 days in basal (control) and differen-
s were immunostained for F-actin (Phalloidin, red), nucleus (Hoechst, yellow),
w) of PEU scaffolds after 28 days of culture in differentiation and basal medium
retation of the references to colour in this figure legend, the reader is referred to
o computed tomography; PEU, poly(ester)urethane.
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morphology with well spread cell bodies (Fig. 1, k). PEU films presented
a higher number of attached cells than TCP after 24 h of seeding (Fig. 1,
j), with cell densities of 4.3.103  0.5 and 3.2.103  0.7 cell/cm2,
respectively, probably due to slight differences on the hydrophilicity of
the two substrates. Cell viability was visualized after 72 h of cell seeding
showing a high amount of viable cells (Fig. 1k, alive) and very few dead
cells (Fig. 1k, dead) for both cells cultured on PEU films and TCP. Cell
viability was quantified from the images and values of 82  4 and
96  2% were measured for PEU and TCP, respectively (Fig. 1, i).
3.4. In vitro cartilage formation
The capability of PEU additive manufactured scaffolds to drive the
differentiation of BMSCs was tested in vitro. BMSCs were cultured for 14
and 28 days in differentiation media on PEU scaffolds with different pore
architectures, namely with a 500 μm pore size and 90 or 60 pattern
(Fig. 1, a-d). As comparison, BMSCs were also cultured on the same
scaffolds in basal media and as pellets in both differentiation and basal
(maintenance) conditions.
3.4.1. Cell proliferation in additive manufactured PEU scaffolds
After 14 and 28 days of BMSC culture in the PEU scaffolds in differ-
entiation and maintenance media, the total DNA content was measured
(Fig. 2, b). For comparison, samples after only 24 h of culture were also
analyzed. The seeding efficiency on PEU scaffolds precoated with trun-
cated human vitronectin was of approximately 50% for 90 and 30% for
60 patterns. Although these values denote a low seeding efficiency,
these are high as compared with non-coated scaffolds (50% and 30%
efficiency vs. 10–20% for both 90 and 60 patterns), which is in line
with other biomaterials used for additive manufacturing and seeded with
BMSCs (Fig. S2)[48,49]. Thus, values of 102⋅103  22⋅103 and 66⋅103 
10⋅103 cells per scaffolds were quantified after 24 h of seeding for the 90
and 60 patterns, respectively (Fig. 2, b). Although a higher tortuosity
was calculated for 90 patterned scaffolds, the surface area was also
higher (549 4 vs 379 20) (Table 2), which explains this difference on
initial cell attachment. Indeed, the cell density (cell number/surface
area) on the scaffolds is similar for both printing patterns, and the cell
surface density (cell number/pore volume) appears to be higher for
scaffolds with a 60 pattern (Figure S3, a and b). After 14 and 28 days of
culture, the cell number remained constant (not significantly different)
for scaffolds with a 90 pattern and slightly increased in 60 scaffolds,
reaching after 28 days of culture values of 106⋅103  10⋅103 and
81⋅103  9⋅103 cells for samples in differentiation and maintenance
media, respectively. No significant differences were found between
samples cultured in differentiation and basal medium. This effect is
commonly observed when culturing BMSCs in additive manufactured
scaffolds [48]. The same observation was done on control pellet cultures
in maintenance and differentiation medium (Fig. S4).
3.4.2. Deposition of specialized extracellular matrix
Articular cartilage has a characteristic extracellular matrix (ECM)
composition that is rich in GAGs and collagen II [50,51]. Thus, it is
important to verify that the composition of the engineered neotissue
resembles that one of the native one. The deposition of GAGs during the
differentiation process was evaluated after 14 and 28 days of culture via
colorimetric quantification from the digested samples and via histo-
logical (Safranin-O) staining. Histological Safranin-O staining and
observation of PEU scaffolds after 14 and 28 days of culture showed a
clear deposition of GAGs (red stain) (Fig. 2, a). The GAG deposition and
distribution of cells was homogenous with similar amounts on the inside
and outside of the scaffolds (Fig. 2, a, top view). The deposition of GAGs
appeared to be similar on differentiation samples as compared with
controls, highlighting the potential of the materials to promote the
deposition of a cartilaginous matrix. The pores of the scaffolds with a
60 pattern presented an apparent higher amount of cells and GAG,7
particularly on differentiation samples after both 14 and 28 days of
culture. Contrary, scaffolds with a 90 pattern appeared to have open
pores, even after 28 days of culture in both media conditions. This vi-
sual observation supports our findings on cell density (Fig. S3). The
deposition of GAGs was also analyzed quantitatively by the
DMMB assay (Fig. 2c and d) for all scaffolds on the different structural
designs. The deposition of GAGs on the scaffolds was overall high with
total GAG values that range from 1 to 2.7 μg after 14 days of culture and
1.3–1.7 μg after 28 days of culture. A decreased GAG deposition was
measured for all the samples at longer culture times, which could be an
indication of ECM remodeling. The deposition after 14 days was higher
in differentiation than in maintenance conditions for both pore struc-
tures (Fig. 2c and d), becoming significant upon normalization to the
total DNA amount (2.24  0.02 vs. 1.4  0.3 μg GAG/μg DNA for 90
patterns and 2.6  0.2 vs. 1.75  0.09 μg GAG/μg DNA for 60 patterns)
(Fig. 2, d). This difference in GAG deposition was, however, compen-
sated after 28 days of culture where values in differentiation and
maintenance conditions were not significantly different (2.34  0.06 vs.
2.2  0.3 μg GAG/μg DNA for 90 patterns and 2.4  0.2 vs.
2.6  0.5 μg GAG/μg DNA for 60 patterns). Comparison between the
density of GAG deposition (GAG/pore volume) and GAG surface density
(GAG/surface area) between scaffolds with different printing patterns
showed that 60 scaffolds present a significantly higher amount of GAGs
after 14 and 28 days of culture in differentiation media than their
counterparts (Figure S5 a and b). These results suggest an optimal cell
differentiation and ECM deposition on scaffolds with this deposition
pattern. As a control, the amount of GAGs deposited by BMSCs cultured
on pellets (gold standard for chondrogenesis in vitro) showed, after 28
days, values of 0.6 and 0.2 μg of GAG per μg of DNA for cells in dif-
ferentiation and culture media, respectively (Fig. S6). These values are
4- and 8-fold lower, than what were measured on the PEU scaffolds.
Moreover, the high values on GAG deposition in both 90 and 60
patterned scaffolds, together with the similar depositions measured for
the differentiation and control conditions after 28 days of culture,
suggest that PEU scaffolds have an intrinsic chondrogenic potential.
The cartilage accounts for a specialized extracellular matrix with a
high percentage of collagen II. Evaluation of the total collagen being
deposited on the FDM scaffolds was performed qualitatively via histology
and the presence of specific collagens (collagen type II and I) via
immunofluorescence. Histological evaluation of collagen deposition was
performed using Picrosirius red staining, a dye that stains all present
collagen types in red/orange. The deposition of collagens on PEU scaf-
folds was overall high (Fig. S7). Collagen (red stain) was visible on the
entire sample with more intense staining on the cell bodies. A compari-
son between samples cultured for 14 or 28 days showed an increase in
collagen deposition over time that was most pronounced in control
samples than in differentiation ones. Moreover, comparison between
these controls and differentiation samples showed no apparent difference
in collagen deposition. The deposition of collagen in the different
structures suggests that a 60 pore shape is preferential for a chondro-
genic differentiation with slightly higher amounts of collagen being
deposited (more intense stain).
The deposition of specific collagens was evaluated via immunofluo-
rescence. BMSCs on pellet cultures showed a high extracellular deposi-
tion of collagen II and only intracellular (nuclear) expression of collagen I
(Fig. S8). PEU scaffolds in differentiation and control conditions after 14
and 28 days of culture were stained for collagen II (blue) and collagen I
(green), F-actin (red), and DNA (yellow) (Fig. 3). Scaffolds with a 90
pattern showed intracellular expression of collagen II in both control and
differentiation samples already after 14 days of culture, which became
more pronounced after 28 days. Scaffolds with a 60 pattern showed
deposition of collagen II in both control andmaintenance conditions after
only 14 days of culture and later (28 days), indicating that the structure
of the scaffolds could be favoring the chondrogenic differentiation of the
cells. The cells within the scaffolds also presented a rather elongated
morphology with cell-cell interactions that are not characteristic of
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3.4.3. Cell invasion and formation of homogeneous tissue
To study the overall cell invasion and tissue formation within the
PEU scaffolds, μCT scans were recorded. Characteristic images of the
3D reconstructions are shown in Fig. 3. Scaffolds printed with a
500 μm and 90 pattern showed a great cell invasion and deposition of
ECM as visualized by the darker fibrous areas present on the core of
the scaffold. Samples in differentiation media seemed to have a higher
cell density or ECM deposition than their counterparts in maintenance
media. Scaffolds with 60 deposition pattern also showed a high cell/
ECM density that again seemed to be higher on the differentiation
condition than that in the control sample. It is noteworthy that the
formation of sheet-like structures bridging the fibers between pores is
probably the result of cell aggregation and ECM deposition, indicative
of tissue formation.
3.4.4. Gene expression profile
To characterize the differentiation state of the cells, their relative
gene expression was analyzed, initially before the experiment and after
14 and 28 days of differentiation (Fig. S9, a, and Fig. 4). The gene
expression profile of cells cultured following the gold standard pellet
culture was also analyzed for comparison (Fig. S9, b, and Fig. 4). BMSCs
before culture in PEU scaffolds showed the characteristic phenotype after
in vitro expansion, with relatively high expression of collagen I, Sox9,
and RunX2. The expression of collagen II and X was low, as well as the
expression of Sox5 and Sox6 (Figs. S9 and a). Upon pellet culture in
chondrogenic media, there was a 6-fold upregulation of both, Sox6 and
Sox5, reaching similar expression values to that of Sox9 (Figs. S9 and a).
Collagen II was also upregulated approximately 6-fold, much higher than
collagen I. The gene expression of collagen I was also upregulated,
although this was within the 2-fold increase range (generally considered
as not significant).
The gene expression of cells cultured on PEU scaffolds after 28 days
showed a similar profile of that of the gold standard pellet cultureFig. 4. Gene expression analysis. Fold increase (a–g) of Sox5, Sox6, Sox9, RunX2, coll
cultured in 500 μm and 90 or 60 patterned scaffolds in differentiation media. (h) Co
bone marrow–derived stem cell.
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(Fig. 4). The gene expression of Sox5 was approximately 6-fold upregu-
lated for both 90 and 60 scaffolds after 14 days. This upregulation
increased after 28 days of culture to 8-fold for both scaffold architectures.
The expression of Sox6 was upregulated by 5- and 6-fold after 14 and 28
days of culture for both scaffold types. Sox9 appeared downregulated by
3- and 2-fold after 14 and 28 days of culture, respectively, which was
similar to pellet cultures. The deposition of collagen I was also upregu-
lated, showing a higher fold increase than that for the pellet cultures and
reaching values of approximately 6-fold after 28 days of culture. The
higher expression of collagen I can be explained as a consequence of the
differentiation media used, containing ascorbate-2-phosphate and
known to stimulate the production of all collagens. Thus, this upregula-
tion is less pronounced in cells cultured on scaffolds in basal media
conditions (Fig. 5). The expression of collagen II was different for scaf-
folds with 90 and 60 patterns, showing an increase over time for the
former and a decrease for the latter. These data confirmed what was
observed by immunofluorescence. That is, a lower deposition of collagen
II was found on the 90 patterns but the increased expression after 28
days may potentially have resulted on a later deposition of the protein if
the scaffolds would have been left in culture for a longer period of time.
Contrary, scaffolds with a 60 pattern showed a higher expression of
collagen II at 14 days than at 28. This could be correlated with the
collagen II deposition that was observed already at day 14 by immuno-
fluorescence. Collagen X and RunX2 appeared both to be upregulated
after 14 and 28 days of culture for both scaffold architectures. In all the
cases, the upregulation was lower than 4-fold.
Cells cultured on PEU scaffolds in maintenance media over 14 and 28
days showed a similar gene expression profile as cells cultured in dif-
ferentiation media (Fig. 5). In this case, however, the fold increase was
smaller as expected. In general, the upregulation of Sox5, Sox6, collagen
I, and collagen II was 2-fold lower than that for cells in differentiation
media. The expression of RunX2 and collagen X was also lower than that
of cells cultured in differentiation media. Taken all together, we suggest
that cells cultured in control conditions have a less chondrogenic
phenotype but still a significant upregulation of chondrogenic markersagen I, collagen II, and collagen X gene expression of BMSCs after 14 and 28 days
llagen II to collagen I relative mRNA expression ratio of the same samples. BMSC,
Fig. 5. Fold increase of (a–g) Sox5, Sox6, Sox9, RunX2, collagen I, collagen II, and collagen X gene expression of hMSCs after 14 and 28 days cultured in 500 μm and
90 or 60 patterned scaffolds in basal media. (h) Collagen II to collagen I relative mRNA expression ratio of the same samples.
Fig. 6. Compressive Young's modulus in PBS of cell-scaffold constructs before
and after 14 and 28 days of culture in basal (maintenance) and differentiation
media. PBS, phosphate buffered saline.
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material and the 3-dimensional culture.
3.4.5. Mechanical properties of the tissue-scaffold constructs
The Young's modulus (E0) under compression in liquid and non-
equilibrium conditions was measured for the different scaffolds after
14 and 28 days of culture. The Young's modulus of PEU scaffolds showed
increasing mechanical properties with longer culture periods, that is,
generally ascribed to an increased amount of deposited ECM and tissue
formation (Fig. 6). Comparison of samples cultured in differentiation and
maintenance media supported the hypothesis that the material itself
promotes the formation of neotissue. The mechanical properties of the
scaffolds at 14 days showed similar Young's modulus for scaffolds with
90 and 60 deposition pattern with values of 1.5  0.2 MPa and
1.5  0.3 MPa, respectively, for scaffolds in differentiation media and
1.3  0.3 MPa and 2.0  0.3 MPa, respectively, in maintenance media.
After 28 days of culture, scaffolds with 90 and 60 printing patterns
displayed a Young's modulus of 3.9  0.5 MPa and 3.0  0.5 MPa,
respectively, in differentiation media and of 2.8  0.9 MPa and
5.8  0.6 MPa, respectively, in maintenance media.
4. Discussion
Biodegradable PEUs, characterized by their elasticity and resilience,
have emerged as potential scaffold materials to replace tissues that
require high resilience and elasticity such as the heart and cartilage [36,
52,53]. However, due to their viscoelastic properties and potential de-
gradability when high temperatures are to be applied, their exploitation
in FDM has only being recently reported by us. We reported on the
fabrication of PEU scaffolds via additive manufacturing, which leads to
elastic materials with a fabrication reproducibility (error) of 4  1% and
an average fiber diameter of 418 5 μm, when a needle of 400 μm (inner
diameter) was used. The additive manufacturing process resulted on an
initial degradation step, with the subsequent decrease on molecular
weight to approximately 80,000 kg/mol, which was then kept constant
during 2 h of continuous deposition [41]. Following this same FDM9
process, scaffolds with a 500-μm fiber spacing and a deposition pattern of
90 and 60 were fabricated. Structural analysis of the scaffolds by SEM
and μCT showed a reproducible and interconnected pore structure with a
closed porosity lower than 3%. The calculated connectivity was higher
for the smaller pore angle structure, which is in agreement with our
previously reported data. A smaller surface area was also measured for
these scaffolds than for that fabricated with a 90 angle.
Cartilage tissue engineering requires of the fabrication of scaffold
materials that are initially capable of supporting the loads applied onto
the knee until the new tissue is formed. The Young's modulus of human
articular cartilage has been determined to be of 0.3 – 0.8 MPa [54,55].
Although fabricating scaffolds capable of supporting such loads has been
shown to be feasible, these are usually too stiff, resulting in low flexibility
(or strain) with strain yields lower than 20%, typically lower than 5%, or
strains that are not recovered upon cyclic load and thus, a mechanical
mismatch between the native and the implanted tissue-scaffold construct
[56–58]. Despite the higher Young's modulus measured for the scaffolds
presented here (3.9 0.5MPa and 3.0 0.5MPa for 90 and 60 patterns,
respectively, after 28 days of culture in differentiation media) as
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occur together with tissue formation, allowing for the restoration of the
native properties of the tissue. Moreover, the knee undergoes repetitive
loading during the day reaching, at the end of the day, strains of up to
20% that are recovered after long periods of rest [1]. Thus, the resilience
of the scaffold is a key parameter. Stress-strain curves from compression
tests of PEU scaffolds revealed extended elastic regimes of 35% and 25%
for 60 and 90 scaffolds, respectively, confirming what we have also
reported previously [41]. Cyclic compression of the PEU scaffolds re-
ported here showed an outstanding recovery after 10 cycles, with
maximum permanent deformation of 1% for the 60 deposition pattern
and only 0.5% for the 90 pattern (Fig. 1). Moreover, it is important to
note that quantification of the permanent deformation after each
compression cycle revealed the appearance of a plateau after 7 and 8
cycles for the 90 and 60 pattern scaffolds, respectively, indicating that
the scaffolds will potentially undergo full shape recovery after further
cycles of compression (Fig. S1). Hung et al. [37] reported on the wet
additive manufacturing of PEU in combination with 24% poly(ethylene
oxide) (PEO) from awater solution for cartilage tissue engineering. Strain
recovery tests on fabricated scaffolds showed a permanent deformation
of approximately 32% and 43%, for PEU/PEO and PEU (after PEO
removal) scaffolds, respectively, after only one compression cycle with
10% strain. Thus, the permanent deformation reported is 43–86 times
higher than the one reported here.
PEU materials supported the growth of BMSCs similarly to traditional
TCP, with no statistical difference on cell viability and a higher cell
attachment after 72 and 24 h. Initial cell attachment on the PEU scaffolds
appeared to be dependent on the available surface area, with higher
values on scaffolds with higher surface area (90 pattern) (Fig. S3). In
long-term culture experiments, however, the cell number remained
constant on 90 scaffolds independently of the media used (basal and
differentiation, Fig. 2) and slightly increased on scaffolds with a 60 pore
architecture, although not statistically significant, which has been
already observed by others on additive manufactured scaffolds using
BMSCs [26].
In vitro cartilage tissue engineering with BMSCs resulted on a depo-
sition of GAGs that ranged from 2.2 to 2.6 μg GAG/μg DNA (Fig. 2). No
significant differences were measured on GAG deposition between the
different pore architectures, as previously observed by Di Luca et al. [26].
Surprisingly, the deposition of GAG was neither significantly different
between the media conditions used and was, for both scaffold architec-
tures, nor higher than that measured on traditional pellet cultures
(Fig. S6). These results seem to indicate that neither the chondrogenic
media nor the 3-dimensional environment is responsible for the deposi-
tion of GAGs in these particular systems but rather the PEU scaffolds
themselves. We recently reported on the in vitro cartilage tissue engi-
neering with these PEU additive manufactured scaffolds and found the
same results when a chondrogenic cell line was used, which further
supports the idea of these being chondroinductive.
The deposition of collagen, a protein characteristic of cartilaginous
tissues, on tissue-engineered scaffolds was also visually examined via
histology, revealing no apparent differences after 28 days of culture on
scaffolds cultured on basal and differentiation media. However, scaffolds
with a 60 pore architecture appeared to be fuller and with a more
intense stain, which suggested a higher deposition of collagen (Fig. S7).
Immunofluorescence staining of collagen I and collagen II supported this
observation. The deposition of collagen II was higher on 60 pore ar-
chitectures than in 90 ones that only showed intracellular expression of
the protein even after 28 days of culture. Moreover, on 60 scaffolds, the
deposition of collagen II was observed in both basal and differentiation
media conditions. Cell invasion and ECM deposition evaluated from μCT
scans further supported this idea, with higher amounts of cell/ECM
observed on 60 scaffolds. We hypothesized that the scaffolds with 60
printing pattern presented a most favorable chondrogenic environment
due to the lower surface area (as compared with 90 scaffolds) which
might promote more cell-cell interactions and reduced focal adhesions on10the substrate material, which has been shown to be favorable for chon-
drogenesis [59]. Indeed, the cell morphology had a rather spindle shape
as compared with chondrocytes in their native environment, which is at
the same time characteristic of BMSCs cultured on additive manufactured
scaffolds [25]. However, similarly to what is observed during cartilage
development, we expect that at longer culture times and with a higher
ECM deposition, cells would be encapsulated within their own matrix,
resulting on the formation of lacunae and acquiring their characteristic
rounded morphology.
Differentiation of stem cells toward chondrogenic phenotypes is a
dynamic process in which cells undergoing chondrogenic differentiation
continue differentiating toward hypertrophic phenotypes, more repre-
sentative of bony environments and with higher expression of collagen I
than that of collagen II. Other markers characteristic of hypertrophic
chondrocytes are RunX2 and collagen X, the latter being only present on
the deep zone of the articular cartilage. The ratio between the expression
of collagen II and collagen I markers is commonly used to characterize
the differentiation state of the cells (more chondrogenic when the ratio is
higher). Other markers representative of chondrogenesis are Sox5, Sox6,
and Sox9, known as the Sox trio, and are necessary for the expression of
collagen II [60]. Analysis of the gene expression profile of BMSCs
cultured on the PEU scaffolds showed an upregulation of characteristic
chondrogenic markers such as collagen II, Sox6, and Sox5, these last two
showing similar relative gene expression as Sox9. The upregulation of
these chondrogenic markers appeared similar to that of cells cultured on
the gold standard pellet culture. Markers of hypertrophy such as collagen
X and collagen I were also upregulated, the last two being higher than
that in pellet cultures. This is likely to be an indication that the differ-
entiation of the cells is still on a premature state similar to that of in vivo
mesenchymal condensation during the development of the osteochon-
dral plate where collagen I is also expressed [61]. Yet, the collagen
II/collagen I expression ratio, which is established as a good marker for
chondrogenic differentiation [62], of approximately 2–3 was measured
after 28 days of culture. Similar values have been reported on the liter-
ature for BMSCs cultured on bulk hydrogels that are traditionally
considered as a favorable chondroinductive environment, yet too weak to
withstand loads applied onto the knee [63].
Analysis of the mechanical properties of the tissue-engineered con-
structs showed an initial decrease on the Young's modulus of the scaffolds
after 14 days of culture, followed by a later increase after 28 days. This
trend is common and ascribed to an initial degradation of the polymer
followed by an increase due to the deposition of ECM.
A detailed observation of the progression on the gene expression of
collagens on cells cultured on both architecture types reveals an unpaired
evolution of the chondrogenic markers. While cells cultured on 90 pore
architectures showed a progressive increase on the expression of collagen
II and decrease on the expression of collagen I and X, cells cultured on 60
pores showed the opposite trend. This is well in line with the observed
trend on collagen II and GAG deposition measured for the two types of
scaffolds, suggesting that cells cultured on 60 patterns undergo faster
chondrogenesis than those cultured on 90 scaffolds. Di Luca et al. [26]
who studied the differentiation of BMSCs on different pore architectures
reported also higher expression levels of collagen II and aggrecan on
scaffolds with a smaller pore angle after 28 days but lower after 14 days,
following the same trend presented here and highlighting the importance
of pore architecture on cell differentiation. Surprisingly, BMSCs cultured
on PEU scaffolds under basal conditions also showed the upregulation of
chondrogenic markers.
Analysis of protein deposition and gene expression of BMSCs cultured
on PEU scaffolds points to an effective differentiation
toward chondrogenic phenotypes. We also observed certain differentia-
tion potential on cells cultured in basal media. This indicates that neither
the media nor the 3D culture environment is the unique driver of the
chondrogenic potential of the scaffolds but rather the PEU itself. Engler
et al. [64] nicely showed the detrimental effect that the matrix elasticity
plays on cell differentiation potential and lineage specification. Recently,
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lineage specification can also be translated to stiffer substrates with
mechanical properties that ranged from 0.8 to 309 MPa, which are more
characteristic of those of cartilage and bone. Although at this moment it
is unclear which is the specific mechanism for the observed chon-
droinduction here, we hypothesized that the elasticity that this
material presents at a macroscopic level is also present at a lower scale.
Thus, cells cultured on the surface of PEU are capable of sensing a me-
chanical environment that is more representative to the one found on
native cartilage.
5. Conclusions
Altogether, the presented data suggest that the biodegradable PEU
used for this study is a good candidate for tissue regeneration of the
articular cartilage. The studied scaffolds with 90 and 60 deposition
patterns and with a pore size of 500 μm showed a good cell invasion and
survival after 14 and 28 days of culture as evidenced by μCT and quanti-
fication of DNA (Figs. 2 and 3). The deposition of a specialized ECM rich in
GAGs was measured, showing good values for 3D printed materials and
was also observed via histological staining (Fig. 2). The deposition of a
collagenous matrix was also observed via staining with Picrosirius red
(Fig. S7). The specific deposition of collagen II and collagen I was assessed
via immunofluorescence (Fig. 3), showing a clear expression of collagen II
in all the samples that was larger on 60 patterned scaffolds, suggesting
that this structure may also contribute to a higher chondrogenic differ-
entiation of the cells. Analysis of the gene expression profile of cells
cultured on PEU scaffolds for 14 and 28 days in differentiation and control
conditions showed for both conditions, an upregulation of chondrogenic
markers such as collagen II, Sox5, Sox6, and Sox9 (Figs. 4 and 5). More-
over, the gene expression profile of scaffolds in differentiationmedia after
28 days of culture was similar to that one measured for the gold standard
for in vitro chondrogenesis, pellet culture (Fig. 4 and Fig. S9). The me-
chanical properties of the scaffolds increased over the culture time
(Fig. 6), whichwe ascribed to the deposition of ECM and tissue formation.
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